Development of an Innovative Point-of-Care Screening Tool for Alzheimer's Disease

开发一种创新的阿尔茨海默病即时护理筛查工具

• 批准号: 569580-2021
• 负责人: Méthot, Nathalie
• 金额: $ 2.19万
• 依托单位: La Cité collégiale
• 依托单位国家: 加拿大
• 项目类别: Applied Research and Development Grants - Level 1
• 财政年份: 2021
• 资助国家: 加拿大
• 起止时间: 2021-01-01 至 2022-12-31
• 项目状态: 已结题
• 来源: https://www.nserc-crsng.gc.ca/ase-oro/Details-Detailles_eng.asp?id=724296
• 关键词: Development; Innovative; Point; Care; Screening

Recherches Neuro-Hippocampe Inc. is a private clinical research institution comprised of physicians and researchers studying Alzheimer's disease for the past 20 years. They are currently conducting Phase 2b and Phase 3 clinical trials at their Ottawa and Gatineau sites. It has been shown that early detection of Alzheimer's disease allows for improved efficacy of therapeutic interventions and quality of life. Therefore, as part of their preclinical program, and in collaboration with two research centers at La Cité, RNH aims to develop a point-of-care diagnostic tool to non-invasively detect risk genes associated with Alzheimer's disease in the younger at-risk population. The Centre for Expertise in Smart Prototyping, and the Technology Access Centre of Bio-Innovation, at La Cité have the expertise in personnel and specialized equipment to help RNH in their endeavor.

Recherches Neuro-Hippocampe Inc. 是一家私人临床研究机构，由过去 20 年来研究阿尔茨海默病的医生和研究人员组成，他们目前正在渥太华和加蒂诺地点进行 2b 期和 3 期临床试验。阿尔茨海默病的检测可以提高治疗干预的效果和生活质量，因此，作为临床前计划的一部分，RNH 与 La Cité 的两个研究中心合作，旨在开发一种药物。 La Cité 的智能原型专业知识中心和生物创新技术获取中心拥有专业知识，可在年轻高危人群中非侵入性地检测与阿尔茨海默病相关的风险基因。人员和专业设备来帮助 RNH 的努力。